Matthew During

No open positions remaining

69 year

Consumer Services

Health Technology

Finance

Profile

Matthew During is the founder of Merlin Pharma Pvt Ltd. (1993), NightstaRx Ltd. (2014), Nightstar Therapeutics Ltd. (2014), and Ovid Therapeutics, Inc. (2014).
At Ovid Therapeutics, Inc., he held the titles of President, Director & Chief Scientific Officer from 2015 to 2019.
Dr. During's former jobs include Senior Manager at Bridgewater Associates LP (2014), Professor-Neurosurgery at Yale University (1989-2000), Professor at Cornell University, and Professor at The Ohio State University (2006-2014).
Dr. During received his undergraduate and doctorate degrees from Auckland University.
Dr. During is also the founder of Neurologix, Inc...

Former positions of Matthew During

Companies	Position	End
OVID THERAPEUTICS INC.	Chief Executive Officer	2015-02-28
Bridgewater Associates LP Bridgewater Associates LP Investment ManagersFinance Bridgewater structures portfolios in a manner designed to produce consistent and uncorrelated returns. The firm believes investors can improve their portfolios’ overall results by separately creating a well-diversified beta portfolio that is balanced against environmental biases and calibrated to one's targeted returns, and a well-diversified alpha portfolio that reduces systematic biases (and is calibrated to one's targeted returns).	Corporate Officer/Principal	2014-11-30
The Ohio State University The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	2014-11-30
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	2005-12-31
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	1999-12-31

See the detail of Matthew During's experience

Training of Matthew During

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew During's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Ovid Therapeutics, Inc. Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders	Health Technology
Bridgewater Associates LP Bridgewater Associates LP Investment ManagersFinance Bridgewater structures portfolios in a manner designed to produce consistent and uncorrelated returns. The firm believes investors can improve their portfolios’ overall results by separately creating a well-diversified beta portfolio that is balanced against environmental biases and calibrated to one's targeted returns, and a well-diversified alpha portfolio that reduces systematic biases (and is calibrated to one's targeted returns).	Finance
Auckland University Auckland University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Ohio State University The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neurologix, Inc. /Old/ Neurologix, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops therapies for the brain and central nervous system	Commercial Services
Merlin Pharma Pvt Ltd. Merlin Pharma Pvt Ltd. Merlin Pharma Pvt Ltd. is a private company based in Mumbai, India.
NightstaRx Ltd. NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies	Health Services
Nightstar Therapeutics Ltd. Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases	Health Technology